PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.47), $0.01 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $94.5 million versus the consensus estimate of $92.76 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.